Drug Type Small molecule drug |
Synonyms- |
Mechanism D2 receptor agonists(Dopamine D2 receptor agonists), D3 receptor agonists(Dopamine D3 receptor agonists) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC31H39N3O3 |
InChIKeyWVYXHYCDEPEXKY-MHZLTWQESA-N |
CAS Registry1619269-47-4 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Parkinson Disease | Preclinical | US | 09 Jul 2014 |